ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  Related Studies  
Focused Versus Enhanced Cognitive Behavioral Therapy for Treating Women With Bulimia Nervosa

This study is currently recruiting participants.
Information provided by National Institute of Mental Health (NIMH)

This Tabular View shows the required WHO registration data elements as marked by

Descriptive Information Fields
Brief Title  Focused Versus Enhanced Cognitive Behavioral Therapy for Treating Women With Bulimia Nervosa
Official Title  Treatment of Bulimia Nervosa: Dysregulated Subtype
Brief Summary

This study will compare the effectiveness of two types of cognitive behavioral therapy in treating adult women with the dysregulated subtype of bulimia nervosa.

Detailed Description

Bulimia nervosa (BN) is a common eating disorder that is characterized by periods of bingeing and purging. People with the dysregulated subtype of BN experience behavioral impulsivity; disruption of cognitive, affective, behavioral, and neurophysiological processes (dysregulation); interpersonal dysfunction; and poor treatment response. To date, no therapies have been tested for this specific population, and it is unknown whether therapy that directly focuses on treating BN symptoms or one that addresses both eating and personality disorder symptoms is more effective. Cognitive behavioral therapy (CBT), which concentrates on modifying patients' behaviors and ways of thinking, has been effective in treating BN. This study will compare the effectiveness of two types of CBT, focused and broad, in treating adult women with the dysregulated subtype of BN.

Participants in this single-blind study will be randomly assigned to receive 20 sessions of either broad (enhanced) or focused CBT. Participants will meet with a therapist once or twice weekly until 20 sessions have occurred. Broad CBT will address symptoms of BN, as well as those of the personality disorder. Focused CBT will concentrate only on BN symptoms. Before treatment begins, participants will complete a set of questionnaires pertaining to their experiences with BN, depression, anxiety, and interpersonal relationships. The questionnaires will be used throughout the study to assess participants' progress. Participants will also attend a clinical interview lasting approximately 3.5 hours. Questions will concern BN, other eating disorder symptoms, depression, anxiety, and interpersonal relationships. Blood samples and vital signs will also be taken at the time of the clinical interview and as needed later in the treatment process.

Study Phase Phase II
Study Type  Interventional
Study Design  Treatment, Randomized, Open Label, Active Control, Parallel Assignment, Safety/Efficacy Study
Primary Outcome Measure  Eating disorder symptoms [ Time Frame: Measured throughout the study ] [ Designated as safety issue: No ]
Secondary Outcome Measure  Depression symptoms [ Time Frame: Measured throughout the study ] [ Designated as safety issue: No ]
Anxiety symptoms [ Time Frame: Measured throughout the study ] [ Designated as safety issue: No ]
Interpersonal relationships [ Time Frame: Measured throughout the study ] [ Designated as safety issue: No ]
Condition  Eating Disorders
Intervention  Behavioral: Cognitive behavioral therapy - focused (CBT-EF)
Behavioral: Cognitive behavioral therapy - broad (EB)
MEDLINE PMIDs
Links
Recruitment Information Fields
Recruitment Status  Recruiting
Enrollment  74
Start Date  July 2007
Completion Date December 2010
Eligibility Criteria 

Inclusion Criteria:

  • Diagnosis of bulimia nervosa
  • Presence of borderline personality disorder features
  • History of one mood or anxiety episode within 2 years prior to study entry
  • If taking psychiatric medication, dose has been stable for at least 6 weeks at time of study entry

Exclusion Criteria:

  • Substance dependence
  • Diagnosis of bipolar I disorder
  • Psychosis
  • Mental retardation
  • Receiving psychosocial treatment
Gender Female
Ages 18 Years to 65 Years
Accepts Healthy Volunteers No
Contacts ††
Contact: Heather Thompson-Brenner, PhD     617-353-9610     ht141@hotmail.com    
Contact: Dana Satir, MA     617-353-9610     dana.satir@gmail.com    
Location Countries  United States
Administrative Information Fields
NCT ID  NCT00494858
Organization ID K23 MH71641
Secondary IDs †† DATR AK-TNAI2
Study Sponsor  National Institute of Mental Health (NIMH)
Collaborators ††
Investigators 
Principal Investigator:     Heather Thompson-Brenner, PhD     Center for Anxiety and Related Disorders, Boston University    
Information Provided By National Institute of Mental Health (NIMH)
Verification Date August 2008
First Received Date  June 28, 2007
Last Updated Date August 19, 2008

 †    Required WHO trial registration data element.
††   WHO trial registration data element that is required only if it exists.




Links to all studies - primarily for crawlers